In trial II ( 2003-2007 ) , the mortality rate was 4.2 per 1000 person-years among children vaccinated in presence of maternal measles antibody and 14.5 per 1000 person-years without measles antibody ( MRR , 0.29 ; 95 % CI , .09 -.91 ) .